Protagenic Therapeutics (PTIX NASDAQ) stock market data APIs
$0.7173
-0.03(-4.2%)
as of March 23, 2026
Try our APIs with
free plan!
Protagenic Therapeutics Financial Data Overview
Price chart is built with
Anychart
Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.
Prev. Close
0.7173
Open
0.6864
High
0.719
Low
0.6748
52 wk Range
0.25-14.28
Market Cap
1 277 K
Shares Outstanding
1 810 K
EPS
-0.47
Beta
0.377
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Protagenic Therapeutics data using free add-ons & libraries
Get Protagenic Therapeutics Fundamental Data
Protagenic Therapeutics Fundamental data includes:
- Net Revenue:
- EBITDA: -5 360 413
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-26
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Protagenic Therapeutics News
New
Protagenic Therapeutics receives Nasdaq non-compliance letter
Protagenic Therapeutics (PTIX [https://seekingalpha.com/symbol/PTIX]) has received a notification letter from Nasdaq indicating its non-compliance with the exchange’s listing rules, namely the minim...
Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice
NEW YORK, NY / ACCESS Newswire / November 27, 2025 / Protagenic Therapeutics, Inc. (Nasdaq:PTIX) (the "Company") today announced that it has received a notification letter from the Nasdaq Listing Qual...
Wondering what's happening in today's after-hours session?
After the closing bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session. [postmarket] AFTER HOURS GAINERS TICKER CHANGE ...
Protagenic Therapeutics provides update on Form 10-Q filing timeline and Nasdaq compliance
* Protagenic Therapeutics (NASDAQ:PTIX [https://seekingalpha.com/symbol/PTIX]) announced on Friday that it expects to file its Quarterly Report on Form 10-Q for the period ended June 30, 2025, in th...
Get Protagenic Therapeutics fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
